- Price
- $50.30
- Day
- -21.79%
- Mkt Cap
- $7.66B
- 52W Range
- $28.53 – $65.30
- Volume
- 8.82M
- Beta
- 1.27
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Read full article
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026. Frank H. Laukien, Bruker's President and CEO, commented: “We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieve.
Read full article
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026.Frank H. Laukien, Bruker's Pre
Read full article
Bruker NASDAQ: BRKR reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research.
Read full article
The Dow is up over 800 points after Monday's rally while upbeat earnings from Palantir (PLTR) is lifting tech and the broader market
Read full article
Bruker (BRKR) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.32 per share a year ago.
Read full article
The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article
Dimensional Fund Advisors LP grew its position in Bruker Corporation (NASDAQ: BRKR) by 23.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,341,518 shares of the medical research company's stock after acquiring an additional 448,440 shares during the
Read full article
Bank of New York Mellon Corp lessened its position in shares of Bruker Corporation (NASDAQ: BRKR) by 6.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 780,955 shares of the medical research company's stock after selling 55,379 shares during the period.
Read full article
On July 28, 2026, Bruker Corp (BRKR) shares rose by 4.8% to a current price of $62.91, reflecting positive momentum in the stock. Over the past year, the shares
Read full article
California Public Employees Retirement System trimmed its position in Bruker Corporation (NASDAQ: BRKR) by 27.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,653 shares of the medical research company's stock after selling 51,544 shares during the quarter. California
Read full article
First Trust Advisors LP increased its position in shares of Bruker Corporation (NASDAQ: BRKR) by 32.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,493,053 shares of the medical research company's stock after acquiring an additional 366,187 shares during the
Read full article